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Background: Bone morphogenetic proteins play important roles in development, morphogenesis and cancer. With
this study we aimed to characterize the response of lung stromal fibroblasts to BMPs and their antagonists on a
genome wide level and investigate its potential role in human lung adenocarcinomas.
Methods: We used an ex vivo culture model and measured gene expression changes in human lung fibroblasts
after stimulation with BMPs and their antagonists using HEEBO microarrays. The in vitro data were correlated with
in vivo observations in published expression datasets of human lung adenocarcinomas.
Results: We have systematically analyzed the response to BMP2, BMP4, BMP7 and their antagonists, Gremlin and
Noggin, to define common and specific gene expression patterns. A BMP2 induced gene expression signature was
defined, which is specific for stromal fibroblasts. Gene expression profiles from lung adenocarcinoma biopsies were
analyzed to determine the prognostic significance of the “Fibroblast specific BMP2 induced gene list”. This gene list
successfully segregated patients with different prognostic outcome in 3 datasets. In a small dataset (Garber et al.)
there was a strong trend for a worse prognosis of patients with adenocarcinomas of all stages over-expressing the
“Fibroblast specific BMP2 induced gene list”. In two larger datasets with stage I adenocarcinomas we observed a
significantly worse disease-free (p = 0.002, Lee et al. and p = 0.002, Bhattacharjee et al.) and overall survival (p = 0.0002).
Conclusions: The effects of BMPs and their antagonists are heterogeneous in different cell types. The gene expression
pattern induced by BMP2 in primary lung fibroblasts may predict outcomes of patients with lung adenocarcinomas.Background
The bone morphogenetic proteins (BMPs) are secreted
signaling molecules that play important roles in numer-
ous aspects of metazoan development, including stem
cell regulation, fate determination, body axis specifica-
tion, cell polarity, proliferation and differentiation [1].
Thus, alterations might play a role in cancer.
In human lung cancer, BMP2 has been shown to be over-
expressed [2]. It activates Smad1/5, thereby increasing Id1
expression and promoting invasion in lung cancer cells [3].
It has long been established that epithelial-mesenchymal
interactions are essential for development and organogen-
esis [4] such as the skin, teeth, gut, and lungs. More re-
cently, it has been recognized that cancer is a tissue-based* Correspondence: Martin.Buess@claraspital.ch
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Increasing evidence suggests that tumorigenesis is
dependent upon contextual signals received from the
stroma [5] and epithelial-mesenchymal interactions are
playing an important role in the initiation and progression
of tumorigenesis. As the tumor develops, the surrounding
stroma provides tumor cells with growth factors and fa-
vorable matrix components that foster proliferation, mi-
gration and colonization of distant organs. In fact, the
reciprocal interaction of stromal cells and carcinoma cells
drives carcinogenesis. The most abundant mesenchymal
cells in the stroma of most tissues and organs are fibro-
blasts. These cells secrete extracellular matrix components
and signaling molecules that contribute to the establish-
ment of customized microenvironments for epithelial cells
and provide a specialized niche for tissue stem cells [6].
Dissecting the molecular mechanisms that underlie cell-
to-cell signaling and crosstalk between epithelial cells, stem
cells, fibroblasts and other stromal cells in tissue microenvi-
ronments is essential to understand normal developmenthis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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element that may play a role in epithelial-mesenchymal in-
teractions in development and cancer – the transcriptional
response of fibroblasts to BMP-induced signals. Given the
multifaceted roles of BMP signaling in these processes [8],
its transcriptional effects on fibroblastic stromal cells are of
great interest. However, in lung cancer, the genome-wide
effects of the involved signaling molecules on stromal fibro-
blasts have not yet been systematically described. Therefore,
to build a systematic foundation of knowledge, we focused
on the effects of BMPs and their antagonists, Gremlin and
Noggin, on transcription in normal human lung fibroblasts.
Importantly, we also demonstrate that the BMP2 gene sig-
nature identified in the lung fibroblasts in vitro has signifi-
cant prognostic relevance in human lung adenocarcinomas
and may thus serve as novel prognostic cancer markers and
therapeutic targets in future.
Methods
Cell culture
Primary human fibroblasts (CCL-171) and the human
breast cancer cell lines MDA-MB-231 and T47D were
obtained from the American Type Culture Collection
(ATTC, Atlanta, Georgia, USA) on 2005 November 15.
After resuscitation the cells were propagated in Dulbecco’s
modified Eagle’s medium (D-MEM, Invitrogen, Carlsbad,
USA) supplemented with 10% heat-inactivated FBS
(Invitrogen, Carlsbad, CA, USA), 4.5 g/l glucose, 4 mM
L-glutamine, 100 U/ml penicillin and 100 μg/ml strepto-
mycin (Gibco, Carlsbad, CA, USA). The cells were main-
tained by regular passages when confluence was reached
and used for the experiments within 3–4 months. The
study was approved by the Ethikkommission beider Basel,
Switzerland (approval No. 271/05).
BMP stimulation experiments
For the experiment, 30’000 cells/cm2 were seeded in 3
ml of 5% FBS D-MEM and incubated for 6 h to allow at-
tachment. The cells were washed extensively with
phosphate-buffered saline and starved for 48 h in fresh
low-serum D-MEM supplemented with 0.2% FBS. The
cells were starved to reduce the effects of any stimulation
from the regular cell culture medium. The medium was
subsequently replaced with fresh low-serum D-MEM with
or without 200 ng/ml BMP2 (human recombinant in
Escherichia coli; Sigma Aldrich, St. Louis, MO, USA), 24
ng/ml BMP4, 200 ng/ml BMP7, 240 ng/ml Noggin or 1
μg/ml Gremlin. The cells were stimulated for 24 h, and
the RNA was harvested to test the effects of BMP and
their antagonists on mRNA expression patterns.
RNA extraction and amplification
After aspirating the culture medium, the cell monolayer
was washed once with phosphate-buffered saline. Thecells were lysed in a buffer containing guanidine isothio-
cyanate (RLT buffer, QIAGEN, CA, USA). The total
RNA was extracted with an RNeasy kit (QIAGEN,
Valencia, CA, USA) according to the manufacturer’s in-
structions. The RNA concentration was measured with a
NanoDrop system spectrophotometer (ND-1000 Spec-
trophotometer Technologies, Wilmington, NC, USA).
The integrity of extracted RNA was assessed by electro-
phoresis in a 1% agarose gel in MOPS buffer. For mRNA
amplification, an Amino Allyl MessageAmp™ II aRNA
Amplification Kit was used (Ambion, Austin, TX, USA).
The amplification of mRNA from 500 ng total RNA,
purification of the cDNA, in vitro transcription and
purification of aRNA were performed according to the
manufacturer’s instructions. The integrity and quantity
of the amplified RNA were verified as described above.
Gene expression analysis with HEEBO arrays
Global gene expression was assessed using the Human
Exonic Evidence Based Oligonucleotide (HEEBO) mi-
croarrays produced at the Stanford Functional Genomic
Facility (Stanford, CA, USA). The HEEBO microarrays
consisted of 44,544 70-mer probes, which included the
following: (a) constitutive exonic probes (30,718); (b) alter-
natively spliced/skipped exonic probes (8,441); (c) non-
coding RNA probes (196); (d) BCR/TCR Genic/regional
probes (372); (e) other probes (843); and (f) controls.
The complete details regarding the clones on the arrays
can be found at the Stanford functional genomics facility
website (https://microarray.org/sfgf/). For the microarray
experiments, 8 μg of amplified RNA (aRNA) was mixed
with the doping controls. The samples were vacuum dried,
resolved in coupling buffer and labeled with Cy5 dye. The
labeled samples were pooled with equal amounts of re-
verse color Cy3-labeled amplified reference RNA from
Stratagene (Stratagene, Santa Rosa, CA, USA). The labeled
aRNA was purified using an AminoAllyl MessageAmp™ II
aRNA Amplification Kit (Ambion) according to the manu-
facturer’s instructions and fragmented using fragmentation
reagents (Ambion). The fragmented probe was added to a
hybridization buffer containing Cot/PolyA/tRNA (0.05 μg/uL
each), 0.3% SDS and 3.3 × SSC supplemented with HEPES
buffer. Following a denaturing step at 100° C, the probe
was placed on the microarray for competitive hybridization.
After 18 h, the slides with hybridized probe were sequen-
tially washed, immediately dried in an ozone-free environ-
ment and scanned using an Axon Scanner 4100A (Axon
Instruments, CA, USA). The data analysis and clustering
Microarray fluorescent image analysis were performed
using the software Genepix Pro version 5.0 3.0.6.89 (Axon
Instruments, Union City, CA, USA). Any spots with obvi-
ous array artifacts or poor technical quality were manually
removed from any further analysis. The raw data files were
stored in the Stanford Microarray Database-Princeton
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cgi-bin/publication/viewPublication.pl?pub_no=1095) [9] as
well as in NCBI’s Gene Expression Omnibus and are
accessible through GEO Series accession number GSE
66142 (http://www.ncbi.nlm.nih.gov/geo/).
Data analysis
The data were expressed as the log2 ratio of the fluores-
cence intensity of the sample and fluorescence intensity
of the reference for each element on the array. A se-
quential data filtering procedure was applied to include
only measurements fulfilling our quality requirements
(i.e. data with a Cy3 channel or Cy5 channel mean inten-
sity over median background intensity greater than 1.5
and a Pearson regression correlation of the pixels within
the spot of greater than 0.6). The genes that did not meet
these criteria for at least 80% of the measurements across
the experimental samples were excluded from further ana-
lysis. The data were evaluated by unsupervised hierarch-
ical clustering with the Cluster® software using Pearson
correlation (non-centered metric) and average linkage and
displayed using TreeView® software [10].
SAM analysis
SAM is a statistical approach to identify genes with ex-
pression patterns that are significantly associated with
specific characteristics of the sample sets [11]. The
Excel-SAM-package version 2.1. was obtained from the
webpage of the Tibshirani Lab: http://statweb.stanford.edu/
~tibs/SAM/. SAM analysis was applied to the BMP dataset
to examine differences between stimulated and unstimu-
lated cells and between cells exposed to different stimuli. A
two-way, unpaired test or a multiclass test was performed
to compare the two groups of interest. A 10-nearest neigh-
bor imputation engine was applied to estimate missing data
[12], and 100 permutations were performed to compute the
expected values and calibrate false positives. The average
amount of imputed values was 5.17 +/− 4.56 percent.
Correlation of gene expression changes upon exposure to
different stimuli
To test for similarities between the expression changes
of single genes upon stimulation with BMP2, BMP4,
BMP7, Noggin and Gremlin we calculated the Pearson
correlation coefficient using the R software (R Develop-
ment Core Team. A language and environment for stat-
istical computing. Available: http://www.R-project.org)
and displayed the results as scatter plots.
Human cancer datasets
The dataset published by Garber and colleagues [13]
contains global gene expression profiles for 67 human
lung cancers derived from 56 patients. 41 of them were
adenocarcinomas with survival data for 24 patients.The dataset published by Lee and colleagues [14] con-
tains global gene expression profiles of 138 human lung
cancers, of which 63 were adenocarcinomas associated
with survival data. The dataset published by Bhattacharjee
[15] contains mRNA expression levels of 12,600 transcript
sequences from 186 lung tumor samples, including 139
adenocarcinomas. Of these, 125 samples were associated
with clinical data (some patients were in multiple runs).
The Bhattacharjee dataset was obtained from the Broad
Institute website, and the Garber dataset was acquired
from the SMD webpage [9]. A list of 156 unique clones
comprising 67 genes building the “Fibroblast specific
BMP2 induced gene list” was extracted from the three
datasets. To avoid possible overweighting of clones from
Unigene clusters that matched more than one probe on
the array, the expression values derived from probes
matched to the same Unigene cluster were averaged. Only
genes that had greater than 80% data values and tumor
samples from patients having complete clinical data were
used. The resulting dataset was subjected to average link-
age unsupervised clustering, and the results were dis-
played using TreeView software [10]. All statistical tests
were performed using the R statistical software (version
2.10.1). Survival curves were obtained using the Kaplan-
Meier estimator and univariate Cox proportional hazards
regression models were fitted (R package “survival”) R
Development Core Team. A language and environment
for statistical computing. Available: http://www.R-project.org.
Accessed 2013 December 2. Hazard ratios and cox
p-values are given to all the curves.
Continuous scoring
The patients in the Lee [14] and the Bhattacharjee data-
sets [15] were stratified based on a continuous score de-
rived from the “Fibroblast specific BMP2 induced gene
list”, as described previously. Briefly, the average expres-
sion level of the genes in the “Fibroblast specific BMP2
induced gene list” was calculated for each patient attrib-
uting a score. The patients were then divided into two
groups, separating them by the median value of the con-
tinuous scores. Only patients with stage I cancers were
included in the survival analysis. Overall survival was
based on the number of deaths from any cause, and the
patients were censored at the final follow up. Disease-
specific survival analysis was based on the number of
deaths caused by the disease, with patients censored at the
last follow-up. In this analysis, patients who died from
other causes were considered alive and censored. The sur-
vival statistics were calculated as described above.
GO::TermFinder analysis
GO::TermFinder uses a list of genes as input and deter-
mines whether those genes have gene ontology (GO) terms
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randomly selected group of genes from the background
population of all of the genes [16]. In our analysis, to
calculate the frequency of particular annotations we
used the gene lists from specific clusters and the full
parental gene lists from the same heatmap as a back-
ground file. For a SAM-derived signature, we used an
input file for SAM analysis as the gene list. For p-value
correction we used the Bonferroni correction method,






























Figure 1 Response of lung stromal fibroblasts (CCL-171) to BMP2
stimulation. Biologically independent duplicate samples of
non-stimulated (Mock) and BMP2 stimulated CCL-171 cells for 24h
were profiled for gene expression changes using HEEBO- microarrays.
After filtering for data quality as described in the methods section,
filtering for data distribution (SD >=0.7) and zero-transformation by the
mean of the non-stimulated samples unsupervised hierarchical clustering
was performed and the data were displayed in a heatmap. The genes
are presented in rows and experiments in columns. Red and green
correspond to up- and down-regulation, respectively. The intensity of
the color reflects the magnitude of the change in the expression level as
depicted on a color key. The genes of interest and the CCL-171 derived
BMP2 signature are indicated.Results
BMP2 stimulation of lung stromal fibroblasts induces
regulatory genes of the BMP signaling pathway
The aim of this study was to uncover the transcriptional
responses to BMP signaling in lung fibroblastic stroma.
To characterize the effects of BMP2 on stromal cells, we
stimulated pre-starved primary human fibroblasts (CCL-
171) with BMP2 in a physiological concentration of
200ng/ml for 24 h. Biologically independent duplicate
samples were profiled for gene expression changes using
human exonic evidence-based oligonucleotide (HEEBO)
microarrays. After filtering for data quality as described
in the methods section, filtering for data distribution
(SD > =0.7) and zero-transformation by the mean of the
duplicate mock control average linkage unsupervised hier-
archical clustering (Pearson correlation) was performed
and the data were presented in a heatmap (Figure 1). Fol-
lowing BMP2 stimulation, we observed a remarkable
change in the gene expression profile. 171 genes exhibited
a greater than 1.5-fold increase (mean: 2.68, standard devi-
ation: 0.86 ) and 206 genes showed a more than 1.5-fold
decrease in the expression level (mean decrease: 2.99,
standard deviation: 1.604) (Additional file 1: Table S1).
A notable feature of the transcriptional response was
the induction of genes with direct roles in the regulation
of BMP signaling either as inhibitors (e.g., BAMBI) or
positive regulators (e.g., BMPR1A). Co-expression of
both negative and positive regulators of BMP signaling
provides a network of opposing control mechanisms that
are likely to contribute to the robust and precise regula-
tion of BMP target gene expression. Furthermore, we de-
tected an up-regulation of BMP target genes such as
SMAD7, ID1, ID2 and ID3. Other genes such as BMP4
and CXCL12 were systematically down-regulated. The
down-regulation of CXCL12 indicates a tie to stem cell
regulation [17]. The “CCL-171-derived BMP2” signature
as marked in Figure 1 (Additional file 2: Table S2), also
contains genes that are known to be involved in devel-
opmental processes, including GATA6, DKK1, ID2,
BAMBI, SERPINE1, and PTGIS.
The identification of transcription factors and other
regulatory genes involved in the transcriptional response(e.g. HEY1, PHTF2, GATA6, and LMCD1) suggests that
a more extensive reprogramming of transcription occurs
downstream of the primary target genes; the mechanism
Rajski et al. BMC Medical Genomics  (2015) 8:16 Page 5 of 12of target gene activation is likely to be far more complex
than direct activation through SMADs, involving a cas-
cade of downstream transcription factors and regulatory
proteins that play a role in further regulation of second-
ary BMP2 target genes. Among the transcription factors
regulated by BMP signal transduction, it was interesting
to find HEY1 and GATA6, which play important roles in
pattern formation, morphogenesis and body-axis specifi-
cation. The increased expression of TPM1, TPM2 and
TNC [18] indicates a fundamental reprogramming of
normal lung fibroblasts such that they exhibited a gene
expression pattern that is typically found in carcinoma-
associated fibroblasts.
For an unbiased assessment of which features are
shared by members of the “CCL-171-derived BMP2” sig-
nature and to verify the significance of enrichment of a
specific gene ontology, we used the GO::TermFinder
tool [16]. The analysis revealed that the “CCL-171-de-
rived BMP2” signature as shown in Figure 1 (Additional
file 2: Table S2) is significantly enriched for genes in-
volved in biological processes such as the cellular re-
sponse to chemical stimuli and the BMP signaling
pathway with Bonferoni corrected p-values of 0.00017
and 0.006, respectively (Additional file 3: Table S3).
Furthermore to identify genes with a significant change
in expression levels we performed a two class unpaired
SAM analysis using a false discovery rate <1%. 76 signifi-
cantly induced and 151 significantly repressed genes after
BMP2 stimulation are shown in Additional file 4: Table
S4. According to our expectations, all the significantly up-
regulated genes are contained within the list of Additional
file 1: Table S1. In addition 10 genes not comprised within
Additional file 1: Table S1 were found to be significantly
down-regulated with SAM analysis, namely: GNG11,
ABHD5, PHF17, GAS1, ARSI, JUN, KLHL29, CHEK2,
ST6GAL1, PDGFRA, H1F0, BTG1 (fold changes of these
genes: 2.15-2.58 fold decrease).
A global picture of genes that are differentially expressed
in response to BMP stimulation or inhibition in lung
stromal fibroblasts
To obtain a more general picture of the transcriptional re-
sponses to BMP signaling, we examined the gene expres-
sion changes in response to physiological concentrations
of BMP2, BMP4, and BMP7, as well as their antagonists,
Noggin and Gremlin, in CCL-171 cells. CCL-171 cells
were starved, and the medium was subsequently replaced
with fresh low-serum D-MEM with or without 200 ng/ml
BMP2 (human recombinant in Escherichia coli; Sigma
Aldrich), 24 ng/ml BMP4, 200 ng/ml BMP7, 240 ng/ml
Noggin, or 1 μg/ml Gremlin. To search for genes with a
significant change in expression upon exposure to at least
one of the agents, we performed a multiclass SAM ana-
lysis on BMP2, BMP4, BMP7, Noggin, Gremlin and mockstimulated biologically independent duplicate samples of
CCL-171 with a false discovery rate of 1% [11] After zero-
transformation with the mean expression levels of the
mock stimulated samples we performed unsupervised
hierarchical clustering of the genes identified by SAM and
displayed the data as a heatmap (Figure 2A). A set of 115
genes was identified that were commonly induced by
BMP2, BMP4 and BMP7 (Additional file 5: Table S5). To
correlate the responses of all genes derived by SAM upon
BMP2 stimulation with the responses to BMP4, BMP7,
Noggin and Gremlin we calculated the Pearson correlation
coefficient r and displayed their correlation as a scatter
plot (Figure 2B). Thus the response to BMP2 observed in
CCL-171 cells was highly significantly correlated to that
observed in response to BMP4 (r = 0.892, p < 0.001) and
BMP7 (r = 0.892, p < 0.001). An expression pattern op-
posing the BMP responses were observed in response to
Noggin (r = −0.940, p < 0.001) and Gremlin (r = −0.924,
p < 0.001), as would be expected for antagonists.
A comparison of the effect of BMP2 stimulation in lung
stromal fibroblasts and breast cancer cells
To determine whether the response to BMP2 is a gen-
eral effect or specific for mesenchymal cells such as the
lung fibroblasts (CCL-171), we compared the gene ex-
pression profile of BMP2-stimulated CCL-171 cells with
the expression profiles of the breast cancer cells MDA-
MB-231 and T47D treated with BMP2. First, to system-
atically define a gene signature reflecting the common
response to BMP2 shared by CCL-171, MDA-MB-231
and T47D cells, we used a two class SAM with block
permutation to identify genes with a significant change
using a false discovery rate of less than 0.8%. A common
set of 80 genes that were significantly induced, and 200
genes that were significantly repressed in all three cell
types were identified (Additional file 6: Table S6).
Second, we intended to determine the cell type specific
gene expression changes upon BMP2 stimulation. The
gene expression levels of CCL-171, MDA-MB-231 and
T47D upon stimulation with BMP2 were subtracted by
the mean expression levels of duplicate samples of the
same cell types with mock stimulation. Genes with a dif-
ference in expression of at least 4 fold were selected and
after unsupervised hierarchical clustering displayed in a
heatmap (Figure 3). We observed a cell type dependent in-
duction or repression of specific genes. We observed
genes that were specifically up- or down-regulated in
CCL-171 cells, including POSTN, a gene that was recently
described to be essential for the formation of metastatic
stem cell niches [19]. The fibroblast-specific up-regulation
of topoisomerases and cyclins indicates an induction of
fibroblast proliferation in response to BMP2 (Figure 3). A
set of 67 genes, which are specifically induced in CCL-171
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Figure 2 Effects of BMP 2, 4 and 7 and gremlin and noggin on CCL-171 cells. A) A multiclass SAM analysis was performed to select for genes that
are differentially expressed in response to BMP2, BMP4, BMP7, Noggin or Gremlin using a FDR of less than 1% as the cut-off value. The selected
genes were organized by unsupervised hierarchical clustering and gene expression changes plotted in a heatmap. The legend bar maps color
versus the magnitude of changes in transcript levels relative to the mock-treatment level. The “common BMP induced gene list” is indicated, and
the genes included in the list are shown in Additional file 5: Table S5. B) Scatter plots demonstrating the correlation of expression changes of all
genes identified by SAM upon stimulation with BMP2 (x-axis) versus BMP4, BMP7, Noggin and Gremlin( y-axis). The Pearson correlation coefficient
r is given. ***corresponds to a p-value < 0.001.
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file 7: Table S7). To support the up-regulation of this clus-
ter in BMP2 stimulated CCL171 cells compared to non-
stimulated CCL-171 cells and compared to MDA-MB-231
and T47D we calculated the average expression levels of
the genes in the cluster (centroid) for each cell line and
condition. A graphic representation of the average expres-
sion value is shown as centroid above the heatmap of the
magnified area in Figure 3.
BMP4 stimulation of lung stromal fibroblasts induces a
time-dependent gene expression signature
To exemplarily show the development of the gene ex-
pression changes in response to BMP stimulation over
time we performed a 48 h time course analysis afterBMP4 stimulation in CCL-171 cells. CCL-171 cells were
first placed under replicative quiescence in DMEM
media with 0.1% serum for 48 h and then exposed to
fully supplemented media, DMEM with 10% serum, and
incubated with BMP4 for 1, 3, 6, 12, 24 or 48 h. The
temporal effect of BMP4 on gene expression was
assessed using DNA microarrays. The BMP4 dependent
changes in the gene expression profiles over time were
assessed by normalization against the time dependent
changes with mock stimulation and normalization against
the gene expression profile at time 0. Some genes were
up-regulated as early as 3 hours, whereas others were
only expressed after 24 hours of stimulation with BMP4
(Figure 4). The strong and highly significant correlation
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Figure 3 Effects of BMP2 stimulation on CCL-171, MDA-MB321 and T47D cells. Biologically independent duplicate samples of CCL-171, MDA-MB-231 and
T4D7 cells were exposed to BMP2 for 24 h. To determine the cell type specific gene expression changes, the mean of the mock gene expression profile
was subtracted from mean of the gene expression profiles of the duplicates of the respective cell type induced by BMP2 for CCL-171, MDA-MB-231 and
T47D. The profiles of induced or repressed genes were merged. Genes with a difference in expression of at least 4 fold were displayed after unsupervised
hierarchical clustering in a heatmap. A set of genes specifically up-regulated in CCL-171, representing the “fibroblast specific BMP2 induced gene list” is
indicated. In the zoomed image the genes of the “fibroblast specific BMP2 induced gene list” are shown for all duplicate samples. The array tree
determined by unsupervised hierarchical clustering using average linkage of all the genes of the arrays is shown to demonstrate consistency of the
duplicates. The mean expression values of all the genes of the “fibroblast specific BMP2 induced gene list” is shown above the cluster of all genes as
expression level of the centroid.
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suggests a concordant and reliable pattern of gene ex-
pression changes in CCL-171 upon 24h of stimulation
by BMP4 and BMP2. This suggests the response to
BMP2 to be suitable for further analysis.
Prognostic significance of the “Fibroblast specific BMP2
induced gene list” in human lung adenocarcinomas
To verify the relevance of our in vitro experiments, we
checked the expression of genes in the “Fibroblast specific
BMP2 induced gene list” (Additional file 7: Table S7) in
publicly available microarray data from lung cancer biop-
sies [13]. Garber et al. published global gene expression
profiles of 41 human lung adenocarcinomas; patient sur-
vival data were available for 24 of these adenocarcinomas
[13] (GEO: GSE3398). A subset of the genes that over-
lapped between the “Fibroblast specific BMP2 induced
gene list” and the Garber dataset (n = 37), was coherent to
provide a basis for segregation of the tumors into twogroups (Figure 5A). As visualized in the Kaplan-Meier
plots, the lung cancer patients with a high expression level
of the “Fibroblast specific BMP2 induced gene list” showed
a strong trend to a higher risk of death than the patients
with a low expression level (76% versus 38% after 12
months, hazard ratio (HR): 0.57, cox-p = 0.07). Thus, the
“Fibroblast specific BMP2 induced gene list” has a potential
to be a prognostic marker in lung cancer.
To further support this finding we analyzed the stage
I lung adenocarcinomas published by Lee et al. [14].
From 67 genes building “Fibroblast specific BMP2 in-
duced gene list” 48 were present in Lee dataset. Patients
stratification based on unsupervised hierarchical clus-
tering divided patients into two groups. Patients carry-
ing tumors with high expression levels of the
“Fibroblast specific BMP2 induced gene list” showed a
significantly higher risk of death than the patients with
a low expression level (76% versus 38% after 24 months,

























































Figure 4 Time course analysis of BMP4 stimulation in CCL-171 cells.
Biologically independent duplicate samples of CCL-171 cells were
exposed to 24 ng/ml BMP4 for 1, 3, 6, 12, or 24 h in parallel with a
mock control. Data were analyzed by unsupervised hierarchical
clustering and plotted as a heatmap. A cluster of genes induced by
BMP4 over time is shown and genes of interest are marked.
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better-annotated dataset published by Bhattacharjee
[15], which contains microarray profiles of 151 stage I
lung adenocarcinomas from patients who had under-
gone surgery. Consistent with our hypothesis, based on
66 genes present in the dataset, the expression of genes
of the “Fibroblast specific BMP2 induced gene list” pro-
vided a basis for segregation of the tumors into two
groups (Figure 6). Compared with patients with low ex-
pression levels of genes in the “Fibroblast specific BMP2
induced gene list” (underlined in red), patients with high
expression levels of these genes (underlined in black) had
a significantly shorter disease-specific survival (87% versus
46% after 5 years, HR: 0.57, cox-p = 0.002) and overall sur-
vival (68% versus 34% after 5 years, HR: 0.51, cox-p =
0.0002). Both Kaplan-Meier curves are shown in Figure 6.
Because the classification of data based on hierarchical
clustering has been suggested to be unstable andcodependent on many factors such as the presence of
missing values [47], we validated the results using continu-
ous scoring and stratified the patients in the Lee and the
Bhattacharjee datasets based on a score derived from the
average expression level of genes in the “Fibroblast specific
BMP2 induced gene list”. The continuous scoring ap-
proach consistently divided the lung cancer patients into
two groups with significantly different outcomes (Lee
dataset: overall survival: HR 0.38, cox-p = 0.00028, Bhatta-
charjee dataset: disease free survival: HR 0.69, cox-p =
0.0023, overall survival: HR 0.72, cox-p =0.027) (Figure 7).
Taken together, these findings indicate that genes included
in the “Fibroblast specific BMP2 induced gene list” are of
importance in vivo in human lung carcinomas and helpful
in predicting outcomes for patients with lung cancer.
Discussion
Gene expression signatures have been described in a
number of studies as surrogate phenotypes to explore
the relevance of in vitro findings in vivo in human can-
cer [20-22]. In this study, we have taken this approach
to explore the effects of BMP stimulation of fibroblastic
stroma in vitro on lung cancer. It has long been estab-
lished that epithelial-mesenchymal interactions are es-
sential for lung development and organogenesis [23].
Given the multifaceted roles of BMP signaling in these
processes [24,25], investigating its transcriptional effects
on fibroblastic stromal cells might improve our under-
standing of lung carcinogenesis. In this study we provide
a comprehensive genomic analysis of gene expression
changes in lung fibroblasts in response to stimulation
with BMP2, BMP4, BMP7 and their antagonists Gremlin
and Noggin. Our results reveal alterations in the expres-
sion of a diverse spectrum of genes, reflecting changes
in various components of key signaling pathways in-
volved in tumorigenesis.
Stimulation of primary human lung fibroblasts with
BMP2 significantly changes their gene expression pat-
tern through signaling via the BMP pathway, as shown
by changes in the expression of genes in the BMP path-
way and BMP target genes, such as BMPR2A, BAMBI,
SMAD7ID1, ID2, and ID3. Of specific interest is the in-
duction of TPM1, TPM2, TNC and POSTN, suggesting
a fundamental reprogramming of lung fibroblasts such
that the cells exhibit a gene expression profile that is
typical for carcinoma-associated fibroblasts. Of specific
interest is also the expression of genes, which might sup-
port cancer stem cells by forming a stem cell niche.
POSTN e.g. has recently been shown to be an essential
component of the metastatic stem cell niche [26]. Prep-
aration of the metastasis location is an essential step in
the cascade of effects leading to the development of fatal
metastatic disease. It would be of great interest to fur-
ther investigate and clarify the role of BMPs in the lung
A B













Figure 5 Prognostic significance of the “Fibroblast specific BMP2 induced gene list” in human lung adenocarcinomas. Unsupervised hierarchical
clustering of the genes in the “Fibroblast specific BMP2 induced gene list” in the Garber and the Lee datasets. (A) The expression values of genes
in the “Fibroblast specific BMP2 induced gene list” were extracted from a published study of genes expressed in 41 lung adenocarcinomas. The
genes are presented in rows and experiments, in columns. The “Fibroblast specific BMP2 induced gene list” stratifies lung adenocarcinomas into
two groups. The Kaplan-Meier curve on the lower panel represents the clinical outcome of the patients with tumors exhibiting high (underlined in
black) and low expression levels (underlined in red) of genes in the “Fibroblast specific BMP2 induced gene list”. (B) Expression of the “Fibroblast specific
BMP2 induced gene list” in stage I lung adenocarcinomas published by Lee et al. Again, the “Fibroblast specific BMP2 induced gene list” segregates lung
adenocarcinomas into two groups which have significantly different clinical outcomes as shown by the Kaplan-Meier curves of overall survival.
Rajski et al. BMC Medical Genomics  (2015) 8:16 Page 9 of 12cancer stem cell niche. Furthermore as a result of the
GO-term analysis, the mRNA expression levels of
GATA6, ID2, AHR, IGFBP7, BAMBI, SERPINE1,
SMAD6, TRNP1, and CYR61 increased in response to
BMP2 stimulation, suggest that BMP2 stimulation of
fibroblasts plays a role in the regulation of cell prolifera-
tion. GATA6, DKK1, ID2, BAMBI, SERPINE1, CYR61 and
PTGIS indicate a positive regulation of a developmentalprocess. The local regulation of diverse cell signaling
pathways by BMP in fibroblasts could therefore have
multifaceted consequences for tissue microenviron-
ments in vivo, including the balance between prolifera-
tion and development. The interconnectivity of these
regulatory systems may contribute to the robustness of



















Figure 6 Prognostic significance of the “Fibroblast specific BMP2 induced gene list” in human stage I lung adenocarcinomas. (A) Unsupervised
hierarchical clustering of the “Fibroblast specific BMP2 induced gene list” in the Bhattacharjee dataset. The expression values of the genes in
the “Fibroblast specific BMP2 induced gene list” were extracted from a published expression study of 151 stage I lung adenocarcinomas. The
“Fibroblast specific BMP2 induced gene list” stratifies lung adenocarcinomas into two groups. (B) The relationship between the expression levels
of genes comprising the “Fibroblast specific BMP2 induced gene list” and the overall and disease-specific survival. The Kaplan-Meier curves
represent the clinical outcomes of the patients.
Rajski et al. BMC Medical Genomics  (2015) 8:16 Page 10 of 12To clarify the in vivo relevance of our in vitro finding
of an activation of the fibroblastic stroma, we correlated
the expression of the “fibroblast specific BMP2 induced
gene list” with the outcome of lung adenocarcinoma bi-
opsies. Up-regulation of the “fibroblast specific BMP2
induced gene list” is associated with a significantly worse
disease-free and overall survival as shown in two data-
sets of operated stage I lung adenocarcinoma patients,
and one set of human lung adenocarcinoma biopsies.
Since segregation of patient samples using unsuper-
vised hierarchical clustering might be unstable and
dependent on missing values, we confirmed the findingusing a more robust approach based on a score derived
from the mean expression values (centroid) of all the
genes in the signature. This suggests that the “fibroblast
specific BMP2 induced gene list” is prognostic in lung
adenocarcinomas. This hints to the in vivo biological
relevance of our in vitro finding of an up-regulation of
this gene list by BMP2 stimulation in lung fibroblasts.
Of note this does not necessarily mean that any gene
subsets or single genes of the “fibroblast specific BMP2
induced gene list” have the same prognostic power, nei-
ther it excludes existence of other, parallel prognostic
signatures.
Overall survival Disease-specific survival
A Lee et al: B Bhattacharjee et al. C  Bhattacharjee et al. 
Overall survival
p=0.025p=0.05p= 0.0003



















Figure 7 Survival analysis of stage I lung adenocarcinomas using continuous scoring of the Lee et al. and the Bhattacharjee et al. datasets. The
relationship between the expression levels of genes comprising the “Fibroblast specific BMP2 induced gene list” and the overall and disease-specific
survival based on continuous scoring as described in the methods section. The Kaplan-Meier curves for (A) overall survival in the Lee et al. dataset and
(B) disease specific survival and (C) overall survival in the Bhattacharjee et al. dataset are presented. The survival-curves of patients with down-regulated
centroid of the “Fibroblast specific BMP2 induced gene list” are encoded in red, with up-regulated centroid in black.
Rajski et al. BMC Medical Genomics  (2015) 8:16 Page 11 of 12In line with our findings, BMP2 has been shown to be
over-expressed in lung cancer [2]. BMP2 serum levels
have been shown to be higher in lung cancer patients
than in normal healthy controls [27]. There was a posi-
tive correlation of tumor burden and tumor stage. Not
surprisingly BMP2 serum levels were correlated with pa-
tient outcome [28]. In our analysis the effect of BMP2
stimulation expressed by the “fibroblast specific BMP2
induced gene list” is correlated with patient outcome
even in the same tumor stage, namely stage I tumors.
This hints to a prognostic relevance of the BMP2 effect
in lung cancer, which is independent from stage and
tumor burden. Further in vitro evidence suggests an es-
sential role of BMP2 in lung cancer. Knockdown experi-
ments of BMP2 in A549 lung adenocarcinoma cells had
shown decreased growth and invasion potential by
changes in the tumor cells gene expression pattern re-
vealing therapeutic targets and strategies [29].
Our analysis of the changes in the expression pattern of
the stromal fibroblasts upon BMP2 stimulation adds add-
itional insights in tumorigenesis and potential therapeutic
targets. Stromal-targeted therapy in lung cancer has not
yet become a clinical reality due to several challenges.
Identification of tumorigenic mechanisms and factors, as
e.g. BMP signaling in stromal cells, is a prerequisite for the
design of potential novel therapeutic strategies.
Conclusion
Bone morphogenetic proteins play important roles in de-
velopment, morphogenesis and cancer. We showed that
the effects of BMPs and their antagonists, gremlin and
noggin, are heterogeneous in different cell types. The
gene expression pattern induced by BMP2 in lungfibroblasts significantly correlated with the prognosis of
patients with stage I lung adenocarcinomas.Additional files
Additional file 1: Table S1. Table of genes with a change in expression
level greater than 1.5-fold after stimulation with BMP2 are color coded.
171 genes induced by BMP2 stimulation are encoded in red (mean fold
up-regulation 2.68 ± 0.86), 206 genes repressed by BMP2 stimulation in
green (mean fold down-regulation 2.99 ± 1.604).
Additional file 2: Table S2. List of the genes building the “CCL-171
derived BMP2 signature”.
Additional file 3: Table S3. GO Term Analysis: The analysis revealed
that the ”CCL-171-derived BMP2 signature” is significantly enriched for
genes involved in biological processes such as the cellular response to
chemical stimuli and the BMP signaling pathway with Bonferoni
corrected p-values of 0.00017 and 0.006, respectively.
Additional file 4: Table S4. Biologically independent duplicated
samples of CCL-171 cells were stimulated with BMP2 and the gene
expression profile assessed with HEEBO microarrays. After filtering for data
quallity as described in the methods section, a two-class unpaired significance
analysis of microarrays was performed on 13601 genes. Genes with a false
discovery rate <1% were selected. 76 genes were significantly induced and
151 genes repressed by BMP2 stimulation of CCL-171 cells.
Additional file 5: Table S5. 115 genes of the “common BMP-induced
gene list”.
Additional file 6: Table S6 SAM results of genes commonly induced
and repressed by BMP2. SAM on 13770 genes after filtering as described
in methods section have been submitted to a multiclass unpaired SAM
with block permuation. Genes with a FDR < 1% were selected. 80 genes
were significantly induced and 200 significantly repressed by BMP2 in
CCL-171, MDA-MB-231 and T47D.
Additional file 7: Table S7. List of the genes building the “Fibroblast
specific BMP2 induced gene list” as indicated in the Figure 4.Competing interests
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